Krystal Biotech, Inc. SEC filings KRYS

Krystal Biotech, Inc. has 513 filings in SEC EDGAR's recent list, going back to Jul 14, 2017. Its latest annual report, Form ARS, was filed on Apr 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.

Krystal Biotech, Inc. SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Nov 2, 2026 Nov 2, 2026
10-Q Quarterly report Nov 2, 2026 Sep 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 30, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 27, 2026 —
8-K Current report
Regulation FD disclosure
Oct 15, 2026 Oct 15, 2026
4 Insider transaction Sep 16, 2026 Sep 14, 2026
4 Insider transaction Sep 16, 2026 Sep 14, 2026
4 Insider transaction Sep 16, 2026 Sep 14, 2026
4 Insider transaction Sep 16, 2026 Sep 14, 2026
4 Insider transaction Sep 16, 2026 Sep 14, 2026
4 Insider transaction Sep 16, 2026 Sep 14, 2026
4 Insider transaction Sep 4, 2026 Sep 4, 2026
4 Insider transaction Sep 4, 2026 Sep 4, 2026
144 Notice of proposed sale Sep 4, 2026 —
144 Notice of proposed sale Sep 4, 2026 —
4 Insider transaction Aug 14, 2026 Aug 14, 2026
144 Notice of proposed sale Aug 14, 2026 —
8-K Current report
Results of operations
Aug 3, 2026 Aug 3, 2026
10-Q Quarterly report Aug 3, 2026 Jun 30, 2026
8-K Current report
Other events
Jul 21, 2026 Jul 21, 2026
4 Insider transaction Jun 26, 2026 Jun 25, 2026
144 Notice of proposed sale Jun 25, 2026 —
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
144 Notice of proposed sale Jun 4, 2026 —
144 Notice of proposed sale Jun 4, 2026 —
4 Insider transaction May 27, 2026 May 26, 2026
144 Notice of proposed sale May 26, 2026 —
8-K Current report
Shareholder vote results
May 20, 2026 May 15, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 4, 2026 —
8-K Current report May 4, 2026 May 4, 2026
10-Q Quarterly report May 4, 2026 Mar 31, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
ARS Annual report to shareholders Apr 3, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 3, 2026 —
DEF 14A Proxy statement Apr 3, 2026 Apr 3, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
3 Initial insider ownership Mar 6, 2026 Mar 1, 2026
3 Initial insider ownership Mar 6, 2026 Mar 1, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
144 Notice of proposed sale Mar 4, 2026 —
144 Notice of proposed sale Mar 4, 2026 —
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Feb 27, 2026 —
4 Insider transaction Feb 26, 2026 Feb 24, 2026
144 Notice of proposed sale Feb 26, 2026 —
144 Notice of proposed sale Feb 25, 2026 —
144 Notice of proposed sale Feb 24, 2026 —
144 Notice of proposed sale Feb 24, 2026 —
4 Insider transaction Feb 23, 2026 Feb 19, 2026
144 Notice of proposed sale Feb 19, 2026 —
8-K Current report
Results of operations
Feb 17, 2026 Feb 17, 2026
10-K Annual report Feb 17, 2026 Dec 31, 2025
4 Insider transaction Feb 11, 2026 Feb 9, 2026
144 Notice of proposed sale Feb 9, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure
Jan 12, 2026 Jan 11, 2026
8-K Current report
Regulation FD disclosure
Jan 8, 2026 Jan 8, 2026
8-K Current report
Officer or director change
Dec 23, 2025 Dec 23, 2025
4 Insider transaction Dec 5, 2025 Dec 4, 2025
4 Insider transaction Dec 5, 2025 Dec 4, 2025
144 Notice of proposed sale Dec 4, 2025 —
144 Notice of proposed sale Dec 4, 2025 —
8-K Current report
Results of operations
Nov 3, 2025 Nov 3, 2025
10-Q Quarterly report Nov 3, 2025 Sep 30, 2025
8-K Current report
Other events
Oct 22, 2025 Oct 22, 2025
8-K Current report
Results of operations
Aug 4, 2025 Aug 4, 2025
10-Q Quarterly report Aug 4, 2025 Jun 30, 2025
8-K Current report
Regulation FD disclosure
Jul 25, 2025 Jul 25, 2025
8-K Current report
Regulation FD disclosure
Jul 24, 2025 Jul 24, 2025
4 Insider transaction Jul 16, 2025 Jul 14, 2025
4 Insider transaction Jul 16, 2025 Jul 14, 2025
4 Insider transaction Jul 11, 2025 Jul 9, 2025
4 Insider transaction Jul 11, 2025 Jul 9, 2025
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 9, 2025 —
8-K Current report
Regulation FD disclosure
Jul 9, 2025 Jul 9, 2025
4 Insider transaction Jun 30, 2025 Jun 30, 2025
4 Insider transaction Jun 30, 2025 Jun 30, 2025
4 Insider transaction Jun 30, 2025 Jun 30, 2025
4 Insider transaction Jun 30, 2025 Jun 30, 2025
4 Insider transaction Jun 30, 2025 Jun 30, 2025
4 Insider transaction Jun 30, 2025 Jun 30, 2025
8-K Current report
Other events
Jun 2, 2025 Jun 2, 2025
8-K Current report
Shareholder vote results
May 19, 2025 May 19, 2025
8-K Current report
Regulation FD disclosure
May 13, 2025 May 12, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Regulation FD disclosure
May 6, 2025 May 5, 2025
8-K Current report
Regulation FD disclosure
Apr 28, 2025 Apr 28, 2025
ARS Annual report to shareholders Apr 3, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 3, 2025 —
DEF 14A Proxy statement Apr 3, 2025 Apr 3, 2025
4 Insider transaction Mar 13, 2025 Mar 13, 2025
4 Insider transaction Mar 13, 2025 Mar 13, 2025
144 Notice of proposed sale Mar 13, 2025 —
144 Notice of proposed sale Mar 13, 2025 —
4 Insider transaction Feb 28, 2025 Feb 26, 2025
4 Insider transaction Feb 28, 2025 Feb 26, 2025
4 Insider transaction Feb 28, 2025 Feb 26, 2025
8-K Current report Feb 28, 2025 Feb 28, 2025
144 Notice of proposed sale Feb 27, 2025 —
8-K Current report
Regulation FD disclosure
Feb 19, 2025 Feb 19, 2025
10-K Annual report Feb 19, 2025 Dec 31, 2024
SCHEDULE 13G Ownership over 5% (passive) Feb 5, 2025 —
8-K Current report
Regulation FD disclosure
Dec 18, 2024 Dec 18, 2024
4 Insider transaction Dec 13, 2024 Dec 13, 2024
4 Insider transaction Dec 13, 2024 Dec 13, 2024
144 Notice of proposed sale Dec 13, 2024 —
144 Notice of proposed sale Dec 13, 2024 —
8-K Current report
Regulation FD disclosure
Dec 12, 2024 Dec 12, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
10-Q Quarterly report Nov 4, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 4, 2024 Nov 4, 2024
SC 13G Ownership over 5% (passive) Oct 16, 2024 —
4 Insider transaction Sep 13, 2024 Sep 12, 2024
4 Insider transaction Sep 13, 2024 Sep 12, 2024
4 Insider transaction Sep 13, 2024 Sep 13, 2024
144 Notice of proposed sale Sep 12, 2024 —
144 Notice of proposed sale Sep 12, 2024 —
8-K Current report
Regulation FD disclosure
Aug 28, 2024 Aug 28, 2024
10-Q Quarterly report Aug 5, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 5, 2024 Aug 5, 2024
SC 13G/A Amended ownership over 5% (passive) Jul 10, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jul 8, 2024 —
4 Insider transaction Jul 1, 2024 Jun 30, 2024
4 Insider transaction Jul 1, 2024 Jun 30, 2024
4 Insider transaction Jul 1, 2024 Jun 30, 2024
4 Insider transaction Jul 1, 2024 Jun 30, 2024
4 Insider transaction Jul 1, 2024 Jun 30, 2024
4 Insider transaction Jul 1, 2024 Jun 30, 2024
4 Insider transaction Jun 11, 2024 Jun 11, 2024
4 Insider transaction Jun 11, 2024 Jun 11, 2024
144 Notice of proposed sale Jun 11, 2024 —
144 Notice of proposed sale Jun 11, 2024 —
4 Insider transaction May 22, 2024 May 20, 2024
8-K Current report
Shareholder vote results
May 21, 2024 May 21, 2024
144 Notice of proposed sale May 20, 2024 —
8-K Current report
Regulation FD disclosure
May 8, 2024 May 7, 2024
10-Q Quarterly report May 6, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 6, 2024 May 6, 2024
DEFA14A Additional proxy material Apr 4, 2024 —
DEF 14A Proxy statement Apr 4, 2024 Apr 4, 2024
4 Insider transaction Mar 11, 2024 Mar 11, 2024
4 Insider transaction Mar 11, 2024 Mar 11, 2024
144 Notice of proposed sale Mar 11, 2024 —
144 Notice of proposed sale Mar 11, 2024 —
4 Insider transaction Mar 1, 2024 Feb 28, 2024
4 Insider transaction Mar 1, 2024 Feb 28, 2024
4 Insider transaction Mar 1, 2024 Feb 28, 2024
4 Insider transaction Mar 1, 2024 Feb 28, 2024
4 Insider transaction Feb 28, 2024 Feb 26, 2024
4 Insider transaction Feb 28, 2024 Feb 26, 2024
4 Insider transaction Feb 28, 2024 Feb 26, 2024
144 Notice of proposed sale Feb 28, 2024 —
144 Notice of proposed sale Feb 26, 2024 —
8-K Current report
Results of operations
Feb 26, 2024 Feb 26, 2024
S-8 Employee stock plan registration Feb 26, 2024 —
10-K Annual report Feb 26, 2024 Dec 31, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 29, 2024 —
4 Insider transaction Jan 24, 2024 Jan 22, 2024
144 Notice of proposed sale Jan 22, 2024 —
4 Insider transaction Dec 12, 2023 Dec 11, 2023
4 Insider transaction Dec 12, 2023 Dec 11, 2023
144 Notice of proposed sale Dec 11, 2023 —
144 Notice of proposed sale Dec 11, 2023 —
8-K Current report
Results of operations
Nov 6, 2023 Nov 6, 2023
10-Q Quarterly report Nov 6, 2023 Sep 30, 2023
144 Notice of proposed sale Oct 2, 2023 —
4 Insider transaction Sep 12, 2023 Sep 11, 2023
4 Insider transaction Sep 12, 2023 Sep 11, 2023
144 Notice of proposed sale Sep 11, 2023 —
144 Notice of proposed sale Sep 11, 2023 —
144 Notice of proposed sale Aug 21, 2023 —
144 Notice of proposed sale Aug 16, 2023 —
144 Notice of proposed sale Aug 15, 2023 —
144 Notice of proposed sale Aug 11, 2023 —
144 Notice of proposed sale Aug 10, 2023 —
8-K Current report
Officer or director change
Aug 7, 2023 Aug 2, 2023
8-K Current report
Results of operations
Aug 7, 2023 Aug 7, 2023
10-Q Quarterly report Aug 7, 2023 Jun 30, 2023
8-K Current report
Regulation FD disclosure
Jul 26, 2023 Jul 26, 2023
S-3ASR Automatic shelf registration Jul 18, 2023 —
4 Insider transaction Jul 3, 2023 Jun 30, 2023
4 Insider transaction Jul 3, 2023 Jun 30, 2023
4 Insider transaction Jul 3, 2023 Jun 30, 2023
4 Insider transaction Jul 3, 2023 Jun 30, 2023
4 Insider transaction Jul 3, 2023 Jun 30, 2023
4 Insider transaction Jul 3, 2023 Jun 30, 2023
4 Insider transaction Jun 9, 2023 Jun 8, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
KRYS (Nasdaq)
Fiscal year ends
December 31
Headquarters
Pittsburgh, PA
SEC filer status
Large accelerated filer
SEC CIK
1711279

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.